Your Messages Inbox (38) 
Your Unread Messages
See All
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment
Current Medical Research and Opinion, 11/06/09
Moton A et al. – The data from this small single–dose study suggest posaconazole is safe. Furthermore, although limited by the small number of subjects enrolled, the authors feel that dose adjustments are probably not necessary in patients with hepatic impairment; however, physicians should continue to monitor posaconazole use in patients with hepatic impairment.
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09
H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09
Antibiotic Use in Neonatal Intensive Care Units and Adherence With Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance
The Pediatric Infectious Disease Journal, 10/29/09
Article Search
Sponsor